Grufity logo
Grufity logo
MAIA

MAIA - MAIA Biotechnology, Inc. Stock Price, Fair Value and News

$1.32-0.04 (-2.94%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

Price Targets

MAIA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MAIA Price Action

Last 7 days

7.9%

Last 30 days

8.7%

Last 90 days

-8.7%

Trailing 12 Months

-20.3%

MAIA RSI Chart

MAIA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MAIA Valuation

Market Cap

82.5M

Price/Earnings (Trailing)

-3.4

Price/Sales (Trailing)

228.35

EV/EBITDA

-3.3

Price/Free Cashflow

-4.14

MAIA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

MAIA Fundamentals

MAIA Revenue

MAIA Earnings

Earnings (TTM)

-24.2M

Earnings Growth (Yr)

-41.01%

Earnings Growth (Qtr)

-75.53%

MAIA Profitability

EBT Margin

-6196.76%

Return on Equity

-87.34%

Return on Assets

-68.65%

Free Cashflow Yield

-24.18%

MAIA Investor Care

Shares Dilution (1Y)

105.06%

Diluted EPS (TTM)

-0.67

MAIA Alerts

  • 2 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2026----
2025---361.4K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About MAIA Biotechnology, Inc.

MAIA
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.
 CEO
 WEBSITEMAIABiotech.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES18

MAIA Biotechnology, Inc. Frequently Asked Questions

MAIA is the stock ticker symbol of MAIA Biotechnology, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of MAIA Biotechnology, Inc. is 82.51 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, MAIA's PE ratio (Price to Earnings) is -3.4 and Price to Sales (PS) ratio is 228.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MAIA PE ratio will change depending on the future growth rate expectations of investors.